Tenoten pills for sucking 40 pcs
Condition: New product
992 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Antibodies to the brain-specific protein S-100
Release form
Pills
Composition
Active ingredient: Antibodies to the brain-specific protein S - 100 affinity purified - 0, 003 g. Additional substances: lactose monohydrate (lactose) 0, 267 g, microcrystalline cellulose 0, 03 g, magnesium stearate 0, 003 g. Protein S - 100 affinity purified - 0, 003g
Pharmacological effect
Pharmacological action - immunomodulatory.
Pharmacokinetics
The sensitivity of modern physicochemical methods of analysis (gas-liquid chromatography, high-performance liquid chromatography, chromatography-mass spectrometry) does not allow to evaluate the content of ultra-low doses of antibodies in biological fluids, organs and tissues, which makes it impossible to study the pharmacokinetics of Ergoferon.
Indications
• neurotic and neurosis-like states, psychosomatic diseases; • stressful disorders with increased nervous tension, irritability, anxiety and vegetative reactions; • moderately pronounced organic lesions of the central nervous system, including traumatic and dyscirculatory origin, accompanied by instability of the emotional background, irritability, memory loss, autonomic disorders.
Contraindications
Increased individual sensitivity, children's age up to 18 years (use of the drug Tenoten for children is shown to children and persons under 18 years of age).
Use during pregnancy and lactation
The safety of using Ergoferon in pregnant women and during breastfeeding has not been studied. During pregnancy and during breastfeeding, the drug is used only if the intended benefit to the mother outweighs the potential risk to the fetus and child. The ratio of benefit / risk is determined by the attending physician.
Dosage and administration
Inside, 1-2 tables. at one time (keep in mouth until completely dissolved) not at meal time. Take 2 times a day; if necessary - up to 4 receptions per day. The course of treatment is 1–3 months; if necessary, the course of treatment can be prolonged up to 6 months or repeated after 1-2 months.
Side effects
When used according to indications and in recommended dosages, no side effects were revealed.Possible reactions increased individual sensitivity to the components of the drug.
Overdose
Symptoms: in case of an accidental overdose, dyspeptic phenomena (nausea, vomiting, diarrhea) are possible, caused by the fillers in the preparation (maltitol, glycerol). Treatment: symptomatic.
Interaction with other drugs
In the course of the clinical trials, no data were obtained on the interaction of Ergoferon with drugs used as concomitant therapy.
special instructions
For lozenges, the drug contains lactose, and therefore it is not recommended to administer it to patients with congenital galactosemia, glucose malabsorption syndrome or galactose, or for congenital lactase deficiency. Effect on ability to drive vehicles and work with mechanisms. It does not affect. For addition solution for oral administration, it is necessary to remember that patients with diabetes mellitus should remember that each tsp (5 ml) of the preparation contains 0.3 g of maltitol, which corresponds to 0.02 XE. Insulin is necessary for the metabolism of maltitol, although due to slow hydrolysis and absorption in the gastrointestinal tract, the need for insulin is low. The energy value of maltitol is 10 kJ or 2.4 kcal / g, which is significantly less than sucrose. The energy value of 1 t.lozhki drug is approximately 5.73 kJ (1.37 kcal). The impact on the ability to drive vehicles and work with mechanisms. Not studied.